Consejo genético en la hiperplasia suprarrenal congénita por déficit de 21-hidroxilasa

[1]  W. Miller,et al.  Prenatal treatment of congenital adrenal hyperplasia: risks outweigh benefits. , 2013, American journal of obstetrics and gynecology.

[2]  P. Speiser,et al.  Congenital adrenal hyperplasia: an update in children , 2011, Current opinion in endocrinology, diabetes, and obesity.

[3]  V. Montori,et al.  Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. , 2010, The Journal of clinical endocrinology and metabolism.

[4]  B. Ezquieta,et al.  Carrier detection and prenatal diagnosis of congenital adrenal hyperplasia must identify ‘apparently mild’ CYP21A2 alleles which associate neonatal salt‐wasting disease , 2010, Prenatal diagnosis.

[5]  P. Hindmarsh,et al.  Mineralocorticoid Deficiency and Treatment in Congenital Adrenal Hyperplasia , 2010, International journal of pediatric endocrinology.

[6]  P. Chatelain,et al.  Surgical options in disorders of sex development (dsd) with ambiguous genitalia. , 2010, Best practice & research. Clinical endocrinology & metabolism.

[7]  F. Waldhauser,et al.  Duplications of the functional CYP21A2 gene are primarily restricted to Q318X alleles: evidence for a founder effect. , 2009, The Journal of clinical endocrinology and metabolism.

[8]  Silvia Parajes,et al.  High Frequency of Copy Number Variations and Sequence Variants at CYP21A2 Locus: Implication for the Genetic Diagnosis of 21-Hydroxylase Deficiency , 2008, PloS one.

[9]  B. Ezquieta,et al.  Gene duplications in 21‐hydroxylase deficiency: the importance of accurate molecular diagnosis in carrier detection and prenatal diagnosis , 2006, Prenatal diagnosis.

[10]  T. Hoogenboezem,et al.  Duplication of the CYP21A2 gene complicates mutation analysis of steroid 21-hydroxylase deficiency: characteristics of three unusual haplotypes , 2002, Human Genetics.

[11]  B. Mendonca,et al.  Variable ACTH-stimulated 17-hydroxyprogesterone values in 21-hydroxylase deficiency carriers are not related to the different CYP21 gene mutations. , 2002, The Journal of clinical endocrinology and metabolism.

[12]  P. White,et al.  Congenital Adrenal Hyperplasia , 1964, The Lancet.